Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03088020 · ClinicalTrials.gov registry record
International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
A clinical trial of Congenital Central Hypoventilation Syndrome, sponsored by Debra Weese-Mayer.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03088020 is a study of Congenital Central Hypoventilation Syndrome that is actively recruiting participants, run by Debra Weese-Mayer. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03088020, a study of Congenital Central Hypoventilation Syndrome, is actively recruiting participants, sponsored by Debra Weese-Mayer.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Center for Autonomic Medicine in Pediatrics (CAMP), in collaboration with leading CCHS clinicians, scientists, and patient advocacy groups around the world has built the first International CCHS (Congenital Central Hypoventilation Syndrome REDCap (Research Electronic Data Capture) Registry. This registry is an international collaboration to capture CCHS natural history data with CCHS patients and their physicians recruited from around the world. This registry is part of a CCHS natural history study that includes the CCHS Secure Health-hub Advancing Research Efforts (CCHS-SHARE), a natural history data platform shared with the broader CCHS research and patient community to house extensive longitudinal, de-identified data. Inclusion of registry data in CCHS-SHARE is optional. The purpose of this IRB-approved research study is to gain a better understanding of the natural history of CCHS, including the various clinical manifestations of CCHS with advancing age, and as related to each patient's specific PHOX2B mutation. With a better understanding of CCHS natural history, we will be able to better anticipate healthcare needs and to provide more accurate guidelines to healthcare providers world-wide in caring for patients with CCHS. The study aims to obtain detailed phenotypic information (information about health and well-being) on patients with CCHS and their families. Participation would require filling out a confidential survey that asks questions regarding phenotype and past medical history. Involvement in the project is completely voluntary and there is no compensation for taking part. However, this project will help us learn more about this disease, with the goal of advancing treatment.
Conditions Studied
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago and the Stanley Manne Children's Research Institute - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2013-06-24 |
| Est. Completion | 2032-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03088020
The ClinicalTrials.gov registry entry for NCT03088020 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Debra Weese-Mayer, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Central Hypoventilation Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03088020 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03088020 about?
NCT03088020 is a clinical study titled "International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE". The Center for Autonomic Medicine in Pediatrics (CAMP), in collaboration with leading CCHS clinicians, scientists, and patient advocacy groups around the world has built the first International CCHS (Congenital Central Hypoventilation Syndrome REDCap (Research Electronic Data Capture) Registry. This...
What is the current status of trial NCT03088020?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2013-06-24. Estimated completion is 2032-12-31.
What conditions does trial NCT03088020 study?
This clinical trial studies the following conditions: Congenital Central Hypoventilation Syndrome.
Who is sponsoring clinical trial NCT03088020?
This trial is sponsored by Debra Weese-Mayer, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03088020 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Central Hypoventilation Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.